Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Varian Medical Systems to Exhibit TrueBeam™ System for Image-Guided Cancer Treatments and New Software Capabilities at ASTRO Meeting in San Diego

October 28, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 28 /- ASTRO Booth # 201 -- Varian Medical Systems (NYSE: VAR ) will highlight its new TrueBeam™ system for fast, powerful and efficient cancer treatments at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) meeting in San Diego next week....

TOPICS:

Scientists call for tighter regulations on food adverts during children's TV viewing

October 28, 2010 11:36 am | by EurekAlert | News | Comments

(University of Liverpool) Psychologists at the University of Liverpool have called for tighter advertising regulations after a study revealed unhealthy foods are more likely to be advertised during children's peak viewing times than at any other point in the broadcasting schedule.

TOPICS:

Huge 'biobank' for research into major diseases to be set up by Qatar and Imperial College London

October 28, 2010 11:36 am | by EurekAlert | News | Comments

(Imperial College London) A "biobank" of samples and clinical measurements from tens of thousands of people is to be established in Qatar to help scientists understand the causes of major diseases and develop new treatments, it is announced today.

TOPICS:
Advertisement

Alliance Seating & Mobility Supports Community Efforts to Help Paralyzed North Carolina Resident

October 28, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

SALISBURY, N.C., Oct. 28 /- Salisbury resident Tim Elrod was severely injured in a vehicle accident approximately one year ago. After several months and multiple hospital stays, he returned home paralyzed from the waist down, confined to a manual wheelchair that was covered by his...

TOPICS:

Technology, New Therapies Reduce Use of Addictive Prescriptions

October 28, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla., Oct. 28 /- The truth is...not all pain is created equal.  Acute pain is where it all begins.  Lasting for several months, acute pain is typically treated with rest, time and medication.  For many, that is enough.   But if the pain persists, it...

TOPICS:

IRIDEX Announces Third Quarter 2010 Conference Call and Release Date

October 28, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 28 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that it will release its third quarter 2010 financial results after the market closes on Thursday, November 4, 2010.  In conjunction with the release, the Company will host a conference call with the...

TOPICS:

FDA Approves Additional Medical Indication for Sprycel

October 28, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Oct. 28 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase...

TOPICS:

Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

October 28, 2010 11:33 am | by AACR | News | Comments

PHILADELPHIA — A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology...

TOPICS:
Advertisement

New Colorectal Screening Test Measures DNA Methylation

October 28, 2010 11:32 am | by AACR | News | Comments

PHILADELPHIA — Results from a validation study of a new DNA methylation screening tool for colorectal cancer will be presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held here Oct. 27-30, 2010.

TOPICS:

FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability

October 28, 2010 11:32 am | by AACR | News | Comments

PHILADELPHIA — Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in...

TOPICS:

Dentsply International's 3Q profit falls

October 28, 2010 10:45 am | by The Associated Press | News | Comments

Dental products maker Dentsply International Inc. said Thursday its third-quarter profit fell nearly 6 percent on higher costs.Dentsply said it earned $63.7 million, or 44 cents per share, down from $67.5 million, or 45 cents per share, a year earlier.Revenue rose 2 percent to $541.8 million...

Omnicare reports 3Q loss on charges

October 28, 2010 10:45 am | by The Associated Press | News | Comments

Omnicare Inc., which sells drugs to nursing homes and long-term care facilities, reported Thursday that it lost $103.3 million in its third quarter because its costs rose and it recorded charges for restructuring and other one-time expenses.The company lost $103.3 million, or 89 cents per...

Multiple sclerosis will become a controlled disease like AIDS

October 28, 2010 10:35 am | by EurekAlert | News | Comments

(IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer) In recent years around 20 genes related to Multiple Sclerosis have been identified. It is expected that in two years there will be about 80 identified genes that will properly define the disease genetic basis. The...

TOPICS:

Aerospace and Defense OEMs Join with SME to Create AeroDef Manufacturing, New Expo, Educational Conference

October 28, 2010 10:34 am | by Society of Manufacturing Engineers | News | Comments

DEARBORN, Mich., October 27, 2010 — The Society of Manufacturing Engineers (SME) today announced the appointment of seven executive committee members for the AeroDef Manufacturing Exposition and Conference, to be held Tuesday–Thursday, April 5-7, 2011 at the Anaheim Convention...

North Shore biotech incubator launches

October 28, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The long-planned Biotech InnoVenture Center is launching in Beverly with a $50,000 grant from the Massachusetts Life Sciences Center and matching funds from private sources.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading